Best Telehealth Clinics in Pennsylvania (2026)

Pennsylvania's telehealth framework went through a significant overhaul in 2024. Governor Shapiro signed Act 42 of 2024 (SB 739) on July 3, 2024, replacing the COVID-era emergency provisions of Act 14 of 2020 with permanent telemedicine law. Act 42 is codified in PA Consolidated Statutes, Title 40, Chapter 48 (Insurance). It requires private health insurers to cover telemedicine services at parity with in-person care, prohibiting exclusions solely because a service was delivered via telemedicine. The law applies to policies filed after March 31, 2025, with full Medicaid and CHIP parity required by January 1, 2026.

The prescribing landscape is more complicated than the insurance law suggests. Under 49 Pa. Code § 16.92, the State Board of Medicine requires an initial medical history and physical examination before prescribing controlled substances, unless emergency circumstances justify otherwise. A medical history and exam from another licensed provider within the preceding 30 days can substitute. The PA Board of Medicine FAQ explicitly warns that if regulations "specifically call for a physical examination to be conducted" and a provider uses telehealth instead, "there could be a violation of the regulation."

The federal DEA extension through December 2026 allows Schedule II through V substances to be prescribed via telehealth without a prior in-person visit. Whether PA's state regulation under § 16.92 creates a stricter standard that survives despite the federal override is a gray area. The DEA's temporary extension is a federal flexibility, not a preemption of state law. In practice, many telehealth TRT providers serve Pennsylvania, relying on the federal extension as their legal basis. But the regulatory uncertainty is real, and it is one reason some providers exclude PA.

Pennsylvania participates in the Interstate Medical Licensure Compact. PA joined the IMLC through 2016 legislation, though full implementation was delayed. The Shapiro administration announced full implementation on July 7, 2025. IMLC applicants for PA face additional requirements: 3 hours of child abuse recognition/reporting education and 4 hours of pain management/opioid prescribing education. PA also participates in the Nurse Licensure Compact (NLC), Psychology Interjurisdictional Compact (PSY), and Physical Therapy Compact (PTC).

Act 96 of 2018 mandates electronic prescribing (EPCS) for Schedule II through V controlled substances, effective October 24, 2019. One notable exception: compounded controlled substance prescriptions are exempt from the EPCS mandate. This means compounded testosterone, which several TRT providers use, does not require e-prescribing in PA.

Pennsylvania has 13 million residents, making it the fifth-largest state. Provider availability is moderate. Several providers list "Most US states" but some specifically exclude PA. The main concern for providers is the § 16.92 physical exam requirement for controlled substances, which creates compliance uncertainty even with the federal DEA override in place.

Feel30, which differentiates on at-home concierge blood draws, excludes Pennsylvania for TRT. Their exclusion list includes PA along with 15 other states. Feel30's enclomiphene service (not a controlled substance) covers all 50 states, so PA patients can access that alternative. The likely reason for the TRT exclusion is the § 16.92 physical exam requirement, which creates compliance risk for telehealth-only TRT providers.

Providers that confirm PA availability for TRT include Maximus (all 50 states, $100/mo with labs), Hone Health (all 50 states, $25/mo entry), TRT Nation ($99/mo, excludes only AL, AK, AR, MO, HI), and providers listing "Most US states" like BraverX ($129/mo with labs), PeterMD ($99/mo annual), DudeMeds ($77/mo), Titan Medical ($99/mo), Male Excel ($99/mo), Blokes ($149/mo), and Defy Medical ($200/mo).

GLP-1 access is unrestricted in Pennsylvania. No semaglutide or tirzepatide limitations apply. Embody ($99/mo), SkinnyRx ($99/mo), DirectMeds ($199/mo), Zealthy ($99/mo), Remedy Meds ($179/mo), GobyMeds ($119/mo), and Sesame Care all serve all 50 states. CareBare, Novi, MEDVi, Shed, Sunlight, and Mochi Health also cover PA.

HRT is fully available. All eight tracked providers, including insurance-accepting Midi Health and PlushCare, serve the state. Hone Health covers all 50 states for women's HRT. All hair loss and ED providers are available. Enhance MD excludes 11 states, and PA is not explicitly listed among them but should be verified.

TRT costs in Pennsylvania are in line with national averages. The same national pricing applies since telehealth rates are set at the company level, not by state. Here is the breakdown of TRT providers available in PA:

DudeMeds: $77/mo (labs $200 extra, true annual $1,124, FDA-approved commercial testosterone). TRT Nation: $99/mo (labs $258 extra, true annual $1,446, unlimited consultations). PeterMD: $99/mo annual (labs included, true annual $1,188, requires upfront annual payment). Maximus: $100/mo annual (labs included, AI coaching, true annual $1,300). Titan Medical: $99/mo (labs $229 extra, true annual $1,417, $49 startup promo). BraverX: $129/mo (labs included, no contract, true annual $1,548). Henry Meds: $129/mo (labs included, true annual $1,548). Blokes: $149/mo (labs included, true annual $1,788). Defy Medical: $200/mo (all delivery methods, labs included, true annual $2,800). Note: Feel30 ($99/mo with labs included, $1,188/year) is not available in PA for TRT.

GLP-1 pricing matches the national range. Entry-level at $99/mo (Embody, SkinnyRx, Zealthy). GobyMeds is $119/mo. Fridays is $117/mo with coaching. Most mid-tier providers charge $179/mo. DirectMeds is $199/mo. TrimRx is the most expensive at $399/mo.

Pennsylvania Medicaid had one of the more progressive GLP-1 coverage policies, covering weight-loss GLP-1s starting in 2023. However, effective January 1, 2026, PA Medicaid ended adult coverage for weight-loss GLP-1s (Wegovy, Zepbound, Saxenda). The PA Department of Human Services issued Medical Assistance Bulletin on November 24, 2025, citing spending growth from $223 million in 2022 to $1.3 billion in 2025. GLP-1s for type 2 diabetes remain covered. Members under 21 may still qualify through EPSDT with prior authorization.

Pennsylvania does not impose sales tax on prescription medications or telehealth services. The state has a flat income tax rate of 3.07%, one of the lowest in the country, though this has no direct impact on telehealth pricing.

HRT: Midi Health (insurance-covered), PlushCare ($20/mo + insurance), Evernow ($35/mo), Alloy ($49/mo), Winona ($99/mo), Hone ($25/mo entry to $149/mo premium). ED: Hims ($17/mo), BlueChew ($20/mo), Ro ($23/mo), Keeps ($25/mo), CareBare ($79/mo), Maximus ($99/mo), MEDVi ($119/mo).

TRT (testosterone replacement therapy)

Pennsylvania's 49 Pa. Code § 16.92 technically requires a physical examination before controlled substance prescribing. The federal DEA extension through 2026 provides a basis for telehealth TRT prescribing without an in-person visit, but the state-level rule creates regulatory gray area. Some providers like Feel30 exclude PA entirely for TRT, citing compliance risk. Compounded controlled substance prescriptions are exempt from PA's electronic prescribing mandate under Act 96 of 2018, which is relevant for providers using compounded testosterone. Both compounded and FDA-approved testosterone are available from providers that do serve the state. Delivery methods include injection, cream, and oral.

GLP-1 weight loss

No state-specific restrictions on semaglutide or tirzepatide in Pennsylvania. Compounded semaglutide follows federal FDA rules after the shortage resolution. PA Medicaid dropped weight-loss GLP-1 coverage as of January 2026, citing a spending increase from $223M to $1.3B in three years. Most PA patients now pay out of pocket through telehealth providers. No PA-specific compounding restrictions exist beyond the federal framework.

HRT (hormone replacement therapy)

HRT follows standard federal prescribing rules in Pennsylvania. No additional state restrictions apply. All eight HRT telehealth providers serve the state. Midi Health and PlushCare accept insurance. Bioidentical compounded hormones are available.

Hair loss

Hair loss treatment follows standard federal prescribing rules in Pennsylvania. No additional state restrictions apply. All major providers serve PA.

ED (erectile dysfunction)

ED treatment follows standard federal prescribing rules in Pennsylvania. No additional state restrictions apply. All seven ED providers on our list serve the state.

Peptides

Peptide therapy follows standard federal rules in Pennsylvania. No state-specific restrictions on sermorelin, BPC-157, or NAD+ were identified. PA's IMLC membership, fully implemented in July 2025, should improve provider availability for newer categories like peptides by making it easier for out-of-state providers to obtain a PA license. Maximus (all 50 states) and Defy Medical ("Most US states") are the most reliably available peptide providers in PA.